Pennsylvania State University, Hershey, Pennsylvania, USA.
University of California San Francisco, San Francisco, California, USA.
BMJ Open Diabetes Res Care. 2019 Dec 11;7(1):e000723. doi: 10.1136/bmjdrc-2019-000723. eCollection 2019.
To understand participant perceptions about insulin and identify key behaviors of healthcare professionals (HCPs) that motivated initially reluctant adults from seven countries (n=40) who had type 2 diabetes (T2D) to start insulin treatment.
Telephone interviews were conducted with a subset of participants from an international investigation of adults with T2D who were reluctant to start insulin (EMOTION). Questions related to: (a) participants' thoughts about insulin before and after initiation; (b) reasons behind responses on the survey that were either 'not helpful at all' or 'helped a lot'; (c) actions their HCP may have taken to help start insulin treatment; and (d) advice they would give to others in a similar situation of starting insulin. Responses were coded by two independent reviewers (kappa 0.992).
Starting insulin treatment was perceived as a negative experience that would be painful and would lead down a 'slippery slope' to complications. HCPs engaged in four primary behaviors that helped with insulin acceptance: (1) showed the insulin pen/needle and demonstrated the injection process; (2) explained how insulin could help with diabetes control and reduce risk of complications; (3) used collaborative communication style; and (4) offered support and willingness to answer questions so that participants would not be 'on their own'. Following initiation, most participants noted that insulin was not 'as bad as they thought' and recommended insulin to other adults with T2D.
Based on these themes, two actionable strategies are suggested for HCPs to help people with psychological insulin resistance: (1) demonstrate the injection process and discuss negative perceptions of insulin as well as potential benefits; (2) offer autonomy in a person-centred collaborative approach, but provide support and accessibility to address concerns. These findings help HCPs to better understand ways in which they can engage reluctant people with T2D with specific strategies.
了解参与者对胰岛素的看法,并确定关键的医疗保健专业人员(HCP)行为,这些行为促使来自七个国家(n=40)的 2 型糖尿病(T2D)初始不愿意接受胰岛素治疗的成年人开始胰岛素治疗。
对一项国际调查中不愿开始使用胰岛素的 T2D 成年人(EMOTION)的参与者进行了电话采访。问题涉及:(a)参与者在开始使用胰岛素前后的想法;(b)调查中回答“一点也没有帮助”或“帮助很大”的原因;(c)他们的 HCP 可能采取的帮助开始胰岛素治疗的行动;以及(d)他们在类似开始胰岛素治疗的情况下会给其他人的建议。响应由两名独立审查员进行编码(kappa 0.992)。
开始胰岛素治疗被视为一种负面体验,会带来痛苦,并会导致并发症的“滑铁卢”。HCP 采取了四种主要行为来帮助接受胰岛素:(1)展示胰岛素笔/针头并演示注射过程;(2)解释胰岛素如何帮助控制糖尿病并降低并发症风险;(3)采用协作沟通方式;以及(4)提供支持并愿意回答问题,以便参与者不会“孤立无援”。开始使用胰岛素后,大多数参与者指出胰岛素“并不像他们想象的那么糟糕”,并向其他 T2D 成年人推荐胰岛素。
基于这些主题,建议 HCP 采取两项可操作的策略来帮助有心理胰岛素抵抗的人:(1)演示注射过程并讨论对胰岛素的负面看法以及潜在的益处;(2)以以患者为中心的协作方式提供自主权,但提供支持和可及性以解决问题。这些发现有助于 HCP 更好地了解他们可以用特定策略与特定策略与 T2D 不情愿的人接触的方式。